Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Abiomed Stock Skyrocketed Today

TheMotleyFool

0 0

Why Abiomed Stock Skyrocketed TodayPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

Shares of Abiomed (NASDAQ: ABMD) soared 50% on Tuesday after the medical device maker struck an acquisition deal with Johnson & Johnson (NYSE: JNJ).

J&J will make a tender offer for Abiomed's publicly traded shares. Under the terms of the agreement, Abiomed's share owners would receive $380 per share in cash, representing an enterprise value of roughly $16.6 billion.

Abiomed shareholders will also earn an additional $35 per share in cash if certain sales and development milestones are reached.

Source Fool.com

Like: 0

ABMD

Teilen